A 1,000mg fish oil softgel and a 300mg ashwagandha hard capsule differ at every manufacturing step. The filling equipment, shell material, and encapsulation process are not the same. A liquid or oil-based formula generally points toward a softgel, while a dry powder blend usually fits a hard capsule. At Leumas, we begin with the formula constraints before discussing appearance or positioning.
What softgels can hold that hard capsules cannot
Softgels use the rotary die process. A ribbon of gelatin or plant-based shell material forms first, then liquid or semi-liquid fill is injected between the layers. The dies close around the fill and seal each unit. This setup suits formulas that need a contained oil or liquid, but it requires dedicated equipment and process control.
Oils and fat-soluble nutrients remain the main softgel applications. Examples include omega-3 from fish oil or algae oil, vitamin D in an oil suspension, vitamin E in the form of tocopherols, and CoQ10 in a lipid base. A softgel can keep these materials together in a consistent unit, whereas a dry hard capsule is not the natural fit for this type of fill.
Softgels can also help with bitter or strongly scented actives. Their hermetic seal keeps taste and odor away from the consumer until the capsule dissolves. Odorless fish oil softgels are a familiar example of that practical benefit.
Hard capsule advantages
Hard two-piece capsules provide more flexibility for dry ingredients. A size 00 HPMC capsule holds up to approximately 950mg of powder, depending on bulk density. Hard capsules can contain one ingredient or a blend, including botanical powders, minerals, and other dry materials suited to the format.
Hard capsule filling is more accessible at smaller batch sizes. At many contract facilities, a run may begin at 500 to 1,000 units. Softgel production has a more involved rotary die setup, so it is usually less practical for a small first run. Leumas can plan a 500-unit pilot, then move toward 5,000-unit production as the formula and demand become clearer.
At equivalent unit counts, hard capsules are generally quicker to manufacture. A line at standard capacity can produce several thousand capsules per hour, while softgel production involves more operational stages. For a growing brand comparing 2,000, 10,000, or larger requirements, the format can affect both scheduling and the point at which a production run becomes practical.
Cost structures differ more than expected
At the same volume, softgels generally cost more per unit than hard capsules. The shell material is one reason: gelatin or plant-based softgel material costs more per unit than the shells used for many hard capsules. The rotary die process and its associated setup also add to the cost structure.
At 5,000-unit production volumes, the softgel premium over a hard capsule is typically 30 to 60 percent for comparable fill weights. The actual difference depends on the shell material, since standard gelatin is usually less costly than a plant-based alternative, as well as the fill and process requirements.
If a formula does not need a liquid or oil fill, selecting a softgel mainly for its appearance or perceived premium can add cost without a matching functional benefit. A dry powder in a softgel is possible in some cases, but it is usually a less direct manufacturing choice than a hard capsule.
Fill material compatibility constraints
Each dosage form has compatibility limits, so the fill should be reviewed before the format is finalized. A softgel fill must be a liquid or suspension with suitable flow and stability. That review can prevent a later reformulation. For an early-stage brand, checking the formula with the manufacturer before committing to tooling is a practical step.
Water-miscible fills can create issues in standard gelatin softgels. Water-based material may interact with the gelatin shell over time, leading to shell softening or fill migration. Formulas with high water content therefore need particular attention during format selection.
Hard capsule fills have different concerns. Hygroscopic materials, including certain mineral salts and some botanical extracts, absorb moisture readily. If moisture is not controlled, the capsule shell can soften during storage. A formulation review should also consider powder flow, bulk density, and how the fill behaves inside the shell.
Matching dosage form to formula and brand
The formula should determine the dosage form first, followed by the target market and brand position. If the active ingredients are oil-based or fat-soluble and depend on a lipid vehicle for absorption, a softgel is often the more suitable choice. For dry botanical, mineral, or blended powder formulas, a hard capsule is usually more direct.
Brand positioning still matters at the margins. A premium omega-3 in a hard capsule is not automatically wrong, but it may conflict with expectations in a category where softgels are common. A botanical adaptogen in a softgel may look distinctive, yet the choice should still make sense for the fill and the added cost. Comparing 4 or 6 format considerations can clarify the tradeoff, but compatibility remains the first filter.
We do not manufacture softgels in-house. Our capsule line produces hard two-piece capsules in HPMC and gelatin. If a founder needs softgel production, we can refer them to specialist softgel CDMOs, but that manufacturing step is not part of Leumas operations. The choice is not which format is better. It is which formula constraints each format can accommodate.